Implementation of Mobile Intensive Care Unit Ultrasound Based Management for Acute Dyspnea
Condition(s) studied
Investigational drug(s) / intervention(s)
Ultrasound pre-hospital care: Use of Ultrasound to guide pre-hospital care for the management of acute dyspnea by the Mobile Emergency Medical Service (SMUR).
Study summary
This multicentre, cluster-randomised, stepped-wedge clinical trial aims to assess whether an intervention designed to implement an ultrasound-guided pre-hospital care pathway for the management of acute dyspnea would improve the effectiveness and efficiency of the mobile emergency medical service (SMUR) compared with standard care.
The order in which centres switch to the intervention (use of ultrasound) will be randomized. The study will begin with an initial 2-month period during which no centre will use ultrasound (standard care). Thereafter, two centers will switch to the intervention phase, and every two months, a further two centres will in turn move into the intervention phase. By the end of the study, all centres will have used ultrasound for at least 2 months.
A total of 800 adults patients treated for acute dyspnea by the SMUR and meeting the inclusion criteria will be enrolled. Each patient's management will be determined by the study phase in effect at their centre at the time of enrolment (control phase without ultrasound or intervention phase with ultrasound).
The appropriateness of treatments administered during SMUR interventions will be compared between the period with ultrasound (intervention phase) and the period without ultrasound (control pahse).
Eligibility
Primary outcome measure(s)
- Score for appropriate treatments administered during the prehospital emergency medical team (SMUR) intervention. — Baseline (at the time of the SMUR's intervention).
1\) This outcome ranges from 0 to 1 (0 = completely inappropriate treatment; 1 = appropriate and effective/minimal treatment). 2) This outcome requires a review of the final diagnosis of acute dyspnea cases treated by the SMUR, as well as an assessment of whether each treatment administered in the SMUR ambulance was appropriate. This review will be conducted by a multidisciplinary team without knowledge of the randomization group.
Trial sites (11)
| Facility | City | Region | Status |
|---|---|---|---|
| Centre Hospitalier d'Argenteuil | Argenteuil | France | |
| CHU Clermont-Ferrand, Hôpital Gabriel Montpied | Clermont-Ferrand | France | |
| Centre Hospitalier Annecy Genevois | Épagny | France | |
| CHU Lille | Lille | France | |
| Groupe Hospitalier de la Région de Mulhouse et Sud Alsace - Hôpital Emile Muller. | Mulhouse | France | |
| Centre Hospitalier Régional Universitaire de Nancy | Nancy | France | |
| Hôpital Lariboisière AP-HP, Paris. | Paris | France | |
| Hôpital de la Pitié Salpêtrière - AP-HP | Paris | France | |
| CHU de Poitiers | Poitiers | France | |
| CHU de Reims | Reims | France | |
| CHU Rouen - Hôpital Charles Nicolle | Rouen | France |
More Central Hospital, Nancy, France trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07852364 on ClinicalTrials.gov ↗ ← All trials in France